Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Both estrogens and androgens are important for health in both males and females.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Testosterone is important for women's health, but more research is needed to guide its use.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Hyperandrogenism does not affect young women's sexual function.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Lower SHBG levels may increase the risk of PCOS.

17b-Estradiol in skin affects hair growth and tumor promotion.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.